Sidra Medicine administers Qatar’s first Itvisma gene therapy for spinal muscular atrophy
Have anything to say about this article?
You can report: fake news, misinformation, error, more information, additional data, etc.
CommentYour comment has been sent successfuly! Thank you.
Sidra Medicine administers Qatar’s first Itvisma gene therapy for spinal muscular atrophy
Tribune News Network Doha Sidra Medicine, a member of Qatar Foundation, has become the first hospital in Qatar to administer Itvisma (onasemnogene abeparvovec), an advanced one-time gene replacement therapy to 13-year-old Khalid, an adolescent living with spinal muscular atrophy (SMA). This milesto»»»
Sidra Medicine administers Qatar's first Itvisma gene therapy for spinal muscular atrophy
One-time gene replacement therapy expands access to precision treatment for eligible children, adolescents, and adults living with spinal muscular atrophy Doha, Qatar: Sidra Medicine, a member of Qatar Foundation, has become the first hospital in Qatar to administer Itvisma™ (onasemnogene abeparvov»»»
Have anything to say about this article?
You can report: fake news, misinformation, error, more information, additional data, etc.
Comment